Jay Lichter, Ph.D.

Jay Lichter, Ph.D.

DirectoratJanux Therapeutics· In proxies 2023–2024

Jay Lichter, Ph.D. sits on 4 public boards.

Boards1

  • Janux TherapeuticsChair · 6 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Janux TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +54%
  2. Aratana Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Synthorx, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Otonomy, Inc.Public company · 15 yr
    • Director2008 – 2023 · 15 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?